Science & Enterprise subscription

Follow us on Twitter

  • Findings from a Pew Research Center survey released this week show more Americans with smartphones use their phones… https://t.co/soaDH8vMqH
    about 15 hours ago
  • New post on Science and Enterprise: Infographic – Phones Top Internet Access Method https://t.co/hdvwSmDiWK #Science #Business
    about 15 hours ago
  • Results from a small-scale clinical trial show an implanted device that stimulates the vagus nerve helps reduce the… https://t.co/V26Ad9owmQ
    about 2 days ago
  • New post on Science and Enterprise: Nerve Stimulation Reduces Arthritis Inflammation https://t.co/Ii2j6AeLHA #Science #Business
    about 2 days ago
  • The Bill and Melinda Gates Foundation is backing research to combine a microscopy technique that grows the size of… https://t.co/nknh7V0ZqG
    about 2 days ago

Please share Science & Enterprise

Patent Awarded for Bone Graft Material Production Process

Model of spine (NIH)

(NIH)

Bacterin International Holdings, a medical device company in Belgrade, Montana received a patent for its technology to produce a form of human bone material suitable for bone grafts that promote regeneration of bone tissue. The U.S. Patent and Trademark Office yesterday issued patent 8,574,825 to seven inventors, including Gregory Juda, Bacterin’s chief scientist, and Steven Scott, who chairs the company’s scientific advisory board, and assigned the patent to the Bacterin.

The patent covers the process for demineralizing bone matter used in bone grafts for procedures such as spinal fusions that encourage the growth of bone tissue to fuse vertebrae in the spine, thus limiting the movement and pain from degenerating discs between vertebrae. The patent document notes that some 1 million bone graft procedures are conducted each year, with about half of those procedures in the U.S.

Demineralized bone matrix is useful when the patient cannot provide his or her own bone matter for a bone graft. However, bone matter from a donor runs risks of rejection or potential infection, as well as less desirable structural properties, such as porosity or density. In addition, synthetic graft materials use putty or gel fillers, which also may not have the same characteristics of natural bone, particularly when those characteristics can vary among different parts of the body.

The process described in the patent subjects donor bone material to an acid solution that removes minerals, while protecting the growth factors that stimulate tissue growth. The patented process allows for periodic pauses to allow for tests of compression or other mechanical properties, and to switch to less acidic solutions until the desired properties are reached.

Bacterin expects to apply the patent to production of its OsteoSponge product, a bone graft material made from human bone, without putty or gel fillers, but is also compressible to allow for better fit during surgical implantation. The company says OsteoSponge provides more surface area as well as signaling molecules that trigger formation of new bone.

Read more:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.